NSGRX | VSCIX | NSGRX / VSCIX | |
Total Expense Ratio | 0.54 | 0.04 | 1,350% |
Annual Report Gross Expense Ratio | 0.59 | 0.04 | 1,475% |
Fund Existence | 26 years | 28 years | - |
Gain YTD | -0.316 | 0.100 | -316% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 347M | 154B | 0% |
Annual Yield % from dividends | 1.04 | 1.38 | 75% |
Returns for 1 year | -9.77 | 9.49 | -103% |
Returns for 3 years | 0.40 | 24.08 | 2% |
Returns for 5 years | 7.67 | 54.42 | 14% |
Returns for 10 years | 24.40 | 109.44 | 22% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRWJX | 27.81 | 0.25 | +0.91% |
MFS Blended Research Growth Eq I | |||
JFNNX | 65.21 | 0.45 | +0.69% |
Janus Henderson Global Life Sciences N | |||
GFFFX | 83.77 | 0.26 | +0.31% |
American Funds Growth Fund of Amer F2 | |||
TMCLX | 8.72 | -0.03 | -0.34% |
Transamerica Energy Infrastructure C | |||
GTDYX | 37.05 | -0.13 | -0.35% |
Invesco EQV Emerging Markets All Cap Y |